More than ten years have passed since the sentinel node (SN) concept for gastric cancer surgery was first discussed. Less invasive modified surgical approaches based on the SN concept have already been put into practice for malignant melanoma and breast cancer, however the SN concept is not yet placed in a standard position in gastric cancer surgery even after two multi-institutional prospective clinical trials, the Japan Clinical Oncology Group trial (JCOG0302) and the Japanese Society for Sentinel Node Navigation Surgery (SNNS) trial. What is the problem in the clinical application of the SN concept to gastric cancer surgery? There is no doubt that we need reliable indicator(s) to determine with certainty the absence of metastasis in the lymph nodes in order to avoid unnecessary lymphadenectomy. There are several matters of debate in performing the actual procedure, such as the type of tracer, the site of injection, how to detect and harvest, how to detect metastases of SNs, and learning period. These issues have to be addressed further to establish the most suitable procedure. Novel technologies such as indocyanine green (ICG) fluorescence imaging and one-step nucleic acid amplification (OSNA) may overcome the current difficulties. Once we know what the problems are and how to tackle them, we can pursue the goal.
Introduction
It is more than 10 years since the sentinel node (SN) concept for gastric cancer surgery was first discussed.(1,2) However, SN for gastric cancer is not yet clinically used universally, although less invasive modified surgical approaches based on the SN concept have already been put into practice for malignant melanoma and breast cancer.
What is the problem in the clinical application of SN in gastric cancer surgery? As a member of the first group to use SN biopsy with indocyanine green (ICG) in gastric cancer surgery,(2) I review here the current status of SN for gastric cancer surgery and discuss these problems.
The Concept of SN in Gastric Cancer Surgery
Gastrectomy with regional lymphadenectomy is indicated for patients with gastric cancer and clinically suspicious lymph node (LN) metastases. The procedure is associated with a satisfactory long-term outcome. This "standard procedure" is usually conducted even when the primary tumor is small. However, there is controversy regarding the application of this procedure for patients with T1 gastric cancer because most of these patients are free of nodal metastases. In terms of the results, it appears that lymphadenectomy is being conducted at far higher rate than necessary in these patients. Thus, we need a reliable indicator that confirms the absence of LN metastases with high accuracy, in order to exclude lymphadenectomy from the surgical procedure used for patients with T1 gastric cancer and preserve a larger volume of the stomach without jeopardizing long-term outcome.
The SN is defined as a LN that directly drains a specific cancer.
The concept of SN is based on the notion that non-SNs are un- With regard to gastric cancer, two Japanese studies were reported around the outset of the 21st century. Hiratsuka et al. (2) reported that SN biopsy using ICG can be performed with a high success rate, and that the SN status can predict the LN status with a high degree of accuracy. Kitagawa et al. (1) the Japan Clinical Oncology Group trial (JCOG0302) and the Japanese Society for Sentinel Node Navigation Surgery (SNNS) trial, were conducted in Japan. The design and results of the two studies showed some rather large differences, as summarized in Table 1 .
The multicenter clinical trial, JCOG0302 (GCSSG-SNB, UMIN-CTR ID: C000000059), was designed to evaluate the feasibility and accuracy of diagnosis using SN biopsy in T1 gastric cancer ( Fig. 1) . In other words, the feasibility of excluding lymphadenectomy during surgery for T1 gastric cancer was evaluated in patients with green nodes, representing SNs detected by ICG, which were considered cancer cell-free, by using intraoperative histopathological examination of frozen sections with hematoxylineosin (H&E) staining. The primary endpoint was the false negative Our pilot study adopted multi-planes for detection of metastases, (2) however, in the multicenter trial setting, only one plane of largest dimension of frozen section was adopted in the trial for conve- 
Matters of Debate
There are several matters of debate in performing the actual procedures, such as the type of tracer, the site of injection, how to detect and harvest, and how to detect metastatic SNs. These issues have to be addressed further to establish the best procedure.
Type of tracer
The dye-guided method is safe, convenient, and cost-effective, whereas legal considerations and costs of radioactive substances limit the probe-guided method in general hospitals.(6,7) However, the dye-guided method has certain limitations, such as loss of visibility in dense fat and rapid transit of the dye, and these limitations are more critical in laparoscopic surgery. Subgroup analyses of meta-analyses showed that the combination of dye and radioactive colloid detection substances is better for detection. (8, 9) Either way, adequate training is required as is evident. (10) (11) (12) ICG is a popular diagnostic reagent approved clinically, (13) and allergic reactions to ICG are fewer than those to blue dye such as isosulfan blue (Lymphazurin   TM   ) . (14) As a tracer for SN biopsy, the injected ICG binds rapidly to albumin and is carried more specifically through the lymphatic vessels than indigo carmine or Evans blue.(15) Some ICG-based novel techniques such as infrared ray electronic endoscopy (16, 17) and ICG fluorescence imaging (18) (19) (20) have been reported as convenient and reliable detection methods for clinical application of this technique using ICG dye (Fig. 2) .
Such newcomers could improve over time the cumbersome procedure of combined tracers.
Site of injection
Theoretically, appropriate injection of tracer is essential for de- The submucosal injection appears to be more reasonable than the subserosal injection in case of luminal organs probably due to accessibility by endoscopy. However, a point to remember is that the indications for SN should include T1 gastric cancer patients with ulceration, who are not suitable for endoscopic resection. Appropriate injection of the tracer in such patients using endoscopy is difficult. On the other hand, subserosal injection into tumors on the lesser curve of the stomach is not easy and that is considered to be impractical in laparoscopic surgery.
How to detect and harvest SNs
The main methods used to detect and harvest SNs are nodes pickup biopsy (2) In principle, however, basin dissection is in conflict with the SN concept, i.e., elimination of LN dissection. I believe we should stick to the main goal of the SN concept.
Learning period
As already stated, a reasonable learning period is about 30 patients, as concluded from the survey conducted the Japanese Society for SNNS. Lee et al. (26) reported that the learning period is 26.
The learning period of just 5 patients for each institution (but not surgeon) advocated by the JCOG0302 trial is presumably an underestimation, and undoubtedly had a negative effect on the results of the trial. Such new technology could overcome the difficulty of securing highly accurate intraoperative diagnosis.
How to detect metastases intraoperatively

Conclusion
Now that we know what the problems are and how to avoid them, we can continue pursuing our goal.
